We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$499M
AUM Growth
+$4.35M
Cap. Flow
-$7.39M
Cap. Flow %
-1.48%
Top 10 Hldgs %
24.94%
Holding
248
New
15
Increased
55
Reduced
102
Closed
20

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.33M
2
MMM icon
3M
MMM
+$4.77M
3
LULU icon
lululemon athletica
LULU
+$4.74M
4
EL icon
Estee Lauder
EL
+$4.6M
5
BLK icon
Blackrock
BLK
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 19.5%
2 Technology 18.93%
3 Financials 12.55%
4 Consumer Discretionary 10.74%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
126
Kinder Morgan
KMI
$69.9B
$896K 0.18%
27,570
+220
+0.8% +$7.37K
FNSR
127
DELISTED
Finisar Corp
FNSR
$895K 0.18%
33,750
-700
-2% -$16.8K
PPL
128
PPL Corp
PPL
$26.5B
$882K 0.18%
28,559
-1,138
-4% -$33K
AEE icon
129
Ameren
AEE
$30.3B
$867K 0.17%
21,035
-3,195
-13% -$123K
CELG
130
DELISTED
Celgene Corp
CELG
$852K 0.17%
12,204
PFE icon
131
Pfizer
PFE
$143B
$826K 0.17%
27,123
-1,199
-4% -$35.7K
SODA
132
DELISTED
SodaStream International Ltd
SODA
$824K 0.17%
+18,675
New +$763K
SHPG
133
DELISTED
Shire pic
SHPG
$817K 0.16%
5,500
MWV
134
DELISTED
MEADWESTVACO CORP
MWV
$816K 0.16%
21,685
-1,940
-8% -$70.6K
TFC icon
135
Truist Financial
TFC
$63.4B
$815K 0.16%
20,299
+92
+0.5% +$3.52K
ARIA
136
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$814K 0.16%
101,000
+32,400
+47% +$252K
DY icon
137
Dycom Industries
DY
$12.5B
$805K 0.16%
25,460
+9,630
+61% +$276K
TYPE
138
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$788K 0.16%
26,150
-600
-2% -$18K
RALY
139
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$779K 0.16%
+58,200
New +$1.16M
SYNA icon
140
Synaptics
SYNA
$4.13B
$768K 0.15%
12,800
+4,000
+45% +$238K
PCRX icon
141
Pacira BioSciences
PCRX
$1.06B
$749K 0.15%
10,700
-4,425
-29% -$301K
VCRA
142
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$738K 0.15%
45,200
-650
-1% -$11K
CTRL
143
DELISTED
Control4 Corporation
CTRL
$729K 0.15%
+34,350
New +$765K
SPNC
144
DELISTED
Spectranetics Corp
SPNC
$717K 0.14%
23,650
-3,850
-14% -$105K
PEGA icon
145
Pegasystems
PEGA
$5.16B
$710K 0.14%
+80,400
New +$868K
WOLF icon
146
Wolfspeed
WOLF
$1.27B
$710K 0.14%
12,546
+750
+6% +$45.7K
GD icon
147
General Dynamics
GD
$103B
$708K 0.14%
6,500
-2,300
-26% -$238K
BUD icon
148
AB InBev
BUD
$166B
$703K 0.14%
6,674
-7,060
-51% -$716K
RARE icon
149
Ultragenyx Pharmaceutical
RARE
$2.46B
$694K 0.14%
+14,200
New +$731K
JPM icon
150
JPMorgan Chase
JPM
$937B
$664K 0.13%
10,941
-783
-7% -$45.3K

Similar funds

Franklin Street Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Franklin Street Advisors held 248 positions worth $499M, up 0.88% from $495M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Franklin Street Advisors's Q1 2014 filing shows 15 new, 55 increased, 102 reduced and 20 closed positions. Its largest new stake was Teva Pharmaceuticals: 115,247 shares worth $6.09M. The largest sale was Jazz Pharmaceuticals, an estimated $6.38M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q1 2014 buy was Teva Pharmaceuticals: 115,247 shares worth $6.09M.
  • Franklin Street Advisors added most to 3M in Q1 2014, an estimated $4.77M increase.
  • Franklin Street Advisors's biggest Q1 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $6.38M.
  • Franklin Street Advisors fully exited CAMERON INTERNATIONAL CORPORATION in Q1 2014, selling an estimated $4.68M.
  • Franklin Street Advisors's ten largest holdings make up 25% of its $499M portfolio in Q1 2014.
  • Franklin Street Advisors opened 15 new positions and closed 20 in Q1 2014.
  • Franklin Street Advisors's portfolio value rose 0.88% quarter-over-quarter to $499M.

Based on Franklin Street Advisors's 13F filing for Q1 2014, filed 4 Apr 2014.